Instructions in package inserts intended for the use of medicines for dyspepsia and constipation during lactation
DOI:
https://doi.org/10.5712/rbmfc19(46)3758Keywords:
Breastfeeding, Mmedicine package inserts, Gastrointestinal Agents, Dyspepsia, Constipation.Abstract
Introduction: The safety and effectiveness of medication use during lactation are concerns for mothers and healthcare professionals. This research analyzes the instructions on the leaflets of medications commonly prescribed for dyspepsia and constipation, which aims to provide essential information to guide therapeutic decisions during this crucial period of motherhood. Objectives: To analyze the information in package inserts about contraindications of drugs for dyspepsia and constipation during breastfeeding, verifying whether these are consistent with scientific evidence. Methods: Drugs for dyspepsia and constipation were selected according to the Anatomical Therapeutic Chemical (ATC) classification and active registry in Brazil. The presence of contraindications for the use of medications in the health professional's and patient's package inserts was compared with the information in the technical manual of the Ministry of Health, Medications and Mothers' Milk, LactMed, UptoDate, Micromedex, Documento Científico da Sociedade Brasileira de Pediatria and Reprotox. Results: No information about use during breastfeeding was found in 20.0 and 24.3% of leaflets for dyspepsia and constipation, respectively. The agreement between the leaflets of medications for dyspepsia and the sources consulted was low (27.2% of the leaflets contraindicated the medication during lactation, while in the sources the percentage of contraindication varied from 0 to 8.3%). In relation to medicines for constipation, 26.3% of the leaflets contraindicated them, while in the sources the percentage ranged from 0 to 4.8%. Conclusions: The study pointed out that at least two out of every ten package inserts for dyspepsia and constipation do not provide adequate information on the use of these drugs in infants, and also shows low concordance between the text of the package inserts and the reference sources regarding compatibility of the drug with breastfeeding.
Downloads
Metrics
References
Brasil. Ministério da Saúde. Saúde da criança: nutrição infantil, aleitamento materno e alimentação complementar. Brasília: Ministério da Saúde; 2009.
Victora CG, Bahl R, Barros AJ, França GV, Horton S, Krasevec J, et al. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet 2016;387(10017):475-90. https://doi.org/10.1016/S0140-6736(15)01024-7 DOI: https://doi.org/10.1016/S0140-6736(15)01024-7
Moimaz SAS, Rós DDT, Saliba TA, Saliba NA. Estudo quanti-qualitativo sobre amamentação exclusiva por gestantes de alto risco. Ciênc Saúde Coletiva 2020;25(9):3657-68. https://doi.org/10.1590/1413-81232020259.30002018 DOI: https://doi.org/10.1590/1413-81232020259.30002018
Saha MR, Ryan K, Amir LH. Postpartum women’s use of medicines and breastfeeding practices: a systematic review. Int Breastfeed J 2015;10:28. https://doi.org/10.1186/s13006-015-0053-6 DOI: https://doi.org/10.1186/s13006-015-0053-6
de Waard M, Blomjous BS, Hol ML, Sie SD, Corpeleijn WE, van Goudoever JHB, et al. Medication use during pregnancy and lactation in a Dutch population. J Hum Lact 2019;35(1):154-64. https://doi.org/10.1177/0890334418775630 DOI: https://doi.org/10.1177/0890334418775630
Silveira MPT, Possignollo J, Miranda VIA, Silveira MFD, Pizzol TDSD, Serrate S, et al. Breastfeeding and risk classification of medications used during hospitalization for delivery: 2015 Pelotas Birth Cohort. Rev Bras Epidemiol 2020;23:e200026. https://doi.org/10.1590/1980-549720200026 DOI: https://doi.org/10.1590/1980-549720200026erratum
Hill M. Critical caveats in using product information/pregnancy categories for pregnant or breastfeeding patients. Aust J Gen Pract 2018;47(12):883-8. https://doi.org/10.31128/AJGP-03-18-4530 DOI: https://doi.org/10.31128/AJGP-03-18-4530
dal Pizzol TS, Moraes CG. Bulas e embalagens de medicamentos como instrumentos de educação em saúde. In: Spinillo CG, Trotta T. Design da informação em saúde. Curitiba: BRioi; 2019. p. 13-47. ISBN 978-85-906855-1-7
Anderson PO, Pochop SL, Manoguerra AS. Adverse drug reactions in breastfed infants: less than imagined. Clin Pediatr (Phila) 2003;42(4):325-40. https://doi.org/10.1177/000992280304200405 DOI: https://doi.org/10.1177/000992280304200405
Lamounier JA. Atualização sobre o uso de medicamentos durante amamentação. Salud(i)ciencia 2005;13(4):10-13.
Agência Nacional de Vigilância Sanitária (ANVISA). Bulário Eletrônico da Agência Nacional de Vigilância Sanitária [Internet]. [cited on January 15, 2021]. Available at: https://consultas.anvisa.gov.br/#/bulario/
Agência Nacional de Vigilância Sanitária (ANVISA). Resolução – RDC no 47, de 8 de setembro de 2009. Estabelece regras para elaboração, harmonização, atualização, publicação e disponibilização de bulas de medicamentos para pacientes e para profissionais de saúde. Diário Oficial da União, 9 set. 2009.
Landis JR, Koch GG. An application of hierarchical Kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 1977;33(2):363-74. https://doi.org/10.2307/2529786 DOI: https://doi.org/10.2307/2529786
Brasil. Ministério da Saúde. Aplicativo MedSUS é disponibilizado para população:
Atualização fornece informações e facilita acesso a medicamentos disponíveis no SUS.
Brasília: Ministério da Saúde; 2024 [Internet]. [cited on Feb 15, 2024]. Available at: https://www.gov.br/saude/pt-br/assuntos/noticias/2024/janeiro/aplicativo-medsus-e-
disponibilizado-para-populacao.
Friedrich C, Richter E, Trommeshauser D, De Kruif S, Van Lersel T, Mandel K, et
al. Absence of excretion of the active moiety of bisacodyl and sodium picosulfate into
human breast milk: an open-label, parallel-group, multiple-dose study in healthy lactating women. DMPK 2011;26(5):458-64. https://doi.org/10.2133/dmpk.DMPK-11-RG-007 DOI: https://doi.org/10.2133/dmpk.DMPK-11-RG-007
Pizzol TDSD, Moraes CG, Diello MV, Campos PM, Pletsch JT, Giugliani C. Uso de medicamentos antidepressivos na amamentação: avaliação da conformidade das bulas com fontes bibliográficas baseadas em evidências científicas. Cad Saúde Pública
;35(2):e00041018. https://doi.org/10.1590/0102-311X00041018 DOI: https://doi.org/10.1590/0102-311x00041018
Pizzol TDSD, Pinto AN, Silveira MPT, Caetano MCDC, Giugliani C. Amamentação e utilização de medicamentos: qual a orientação presente nas bulas de anticoncepcionais e anti-infecciosos?. Ciênc Saúde Coletiva 2021;26(10):4783-94. https://doi.org/10.1590/1413-812320212610.30702020 DOI: https://doi.org/10.1590/1413-812320212610.30702020
Arguello B, Salgado TM, Fernandez‐Llimos F. Assessing the information in the
Summaries of Product Characteristics for the use of medicines in pregnancy and lactation. Br J Clin Pharmacol 2015;79(3):537-44. https://doi.org/10.1111/bcp.12515 DOI: https://doi.org/10.1111/bcp.12515
Davanzo R. Controversies in breastfeeding. Front Pediatr 2018;6:278. https://doi.org/10.3389/fped.2018.00278 DOI: https://doi.org/10.3389/fped.2018.00278
Weersink RA, Timmermans L, Monster-Simons MH, Mol PG, Metselaar HJ, Borgsteede SD, et al. Evaluation of information in summaries of product characteristics (SmPCs) on the use of a medicine in patients with hepatic impairment. Front Pharmacol
;10:1031. https://doi.org/10.3389/fphar.2019.01031 DOI: https://doi.org/10.3389/fphar.2019.01031
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Danillo Alencar Roseno, Tatiana da Silva Sempé, Thanyse de Oliveira Schmalfuss, Camila Giugliani, Tatiane da Silva Dal Pizzol
This work is licensed under a Creative Commons Attribution 4.0 International License.
By submitting a manuscript to the RBMFC, authors retain ownership of the copyright in the article, and authorize RBMFC to publish that manuscript under the Creative Commons Attribution 4.0 license and identify itself as the vehicle of its original publication.
